185 related articles for article (PubMed ID: 23452727)
1. Rapid screening and identification of dominant B cell epitopes of HBV surface antigen by quantum dot-based fluorescence polarization assay.
Meng Z; Song R; Chen Y; Zhu Y; Tian Y; Li D; Cui D
Nanoscale Res Lett; 2013 Mar; 8(1):118. PubMed ID: 23452727
[TBL] [Abstract][Full Text] [Related]
2. [Detection of antibody against Helicobacter pylori UreB by fluorescence polarized immunoassay using single epitope synthetic peptide as antigen].
Zhang WH; Wang Y; Guo HF; Bai YJ; Yan XJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):371-4. PubMed ID: 15862161
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
4. Identification and Mapping of HBsAg Loss-Related B-Cell Linear Epitopes in Chronic HBV Patients by Peptide Array.
Gu S; Liu Z; Lin L; Zhong S; Ma Y; Li X; Ye G; Wen C; Li Y; Tang L
Front Immunol; 2021; 12():767000. PubMed ID: 34721439
[TBL] [Abstract][Full Text] [Related]
5. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
7. [Localization of the immunodominant site in the hepatitis B virus core antigen using synthetic peptides].
Semiletov IuA; Karpova VA; Kalinina TI; Khudiakov IuE
Bioorg Khim; 1994 Nov; 20(11):1175-85. PubMed ID: 7880177
[TBL] [Abstract][Full Text] [Related]
8. Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus.
Tencza SB; Islam KR; Kalia V; Nasir MS; Jolley ME; Montelaro RC
J Clin Microbiol; 2000 May; 38(5):1854-9. PubMed ID: 10790112
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against non-dominant epitopes of HBV e Ag was raised by antigen-antibody co-immunization.
Yan LC; Jing CY; Huang CF; Ji YY; Yao G; Cai XF; Sun B
J Biotechnol; 2007 May; 129(4):620-7. PubMed ID: 17408795
[TBL] [Abstract][Full Text] [Related]
10. Identification of surface-exposed linear B-cell epitopes of the nonfimbrial adhesin CS31A of Escherichia coli by using overlapping peptides and antipeptide antibodies.
Méchin MC; Rousset E; Girardeau JP
Infect Immun; 1996 Sep; 64(9):3555-64. PubMed ID: 8751899
[TBL] [Abstract][Full Text] [Related]
11. Screening and Identification of HBV Epitopes Restricted by Multiple Prevalent HLA-A Allotypes.
Ding Y; Zhou Z; Li X; Zhao C; Jin X; Liu X; Wu Y; Mei X; Li J; Qiu J; Shen C
Front Immunol; 2022; 13():847105. PubMed ID: 35464415
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Molecular Serology of Human
Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Lee DE; Kaltenboeck B
mSphere; 2018 Aug; 3(4):. PubMed ID: 30068559
[TBL] [Abstract][Full Text] [Related]
13. Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay.
Bottino CG; Gomes LP; Pereira JB; Coura JR; Provance DW; De-Simone SG
BMC Infect Dis; 2013 Dec; 13():568. PubMed ID: 24299278
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
[TBL] [Abstract][Full Text] [Related]
15. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
[TBL] [Abstract][Full Text] [Related]
17. The Use of Molecular Dynamics Simulation Method to Quantitatively Evaluate the Affinity between HBV Antigen T Cell Epitope Peptides and HLA-A Molecules.
Mei X; Li X; Zhao C; Liu A; Ding Y; Shen C; Li J
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563019
[TBL] [Abstract][Full Text] [Related]
18. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.
Tordjeman M; Fontan G; Rabillon V; Martin J; Trepo C; Hoffenbach A; Mabrouk K; Sabatier JM; Van Rietschoten J; Somme G
J Med Virol; 1993 Nov; 41(3):221-9. PubMed ID: 7505307
[TBL] [Abstract][Full Text] [Related]
19. A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody.
Thanavala YM; Brown SE; Howard CR; Roitt IM; Steward MW
J Exp Med; 1986 Jul; 164(1):227-36. PubMed ID: 2425029
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
